Doctor profile · Federal record
Dr. Steven Liu, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Anchorage, AK
- NPI 1164462834
- Accepts Medicare
- MIPS 65.5 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2925 Debarr RD, Suite 300
Anchorage, AK 995082983
(907) 279-3155
fax (907) 279-3154
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- November 23, 2021
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Alaska #5645
- Medicaid
- AK #MD3340
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164462834. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
134,876
Distinct HCPCS
10
Medicare allowed
$4,319,989
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 35,800 | 31 | $53 | |
J9299 |
Injection, nivolumab, 1 mg | 24,400 | 11 | $30 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 15,900 | 14 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 12,960 | 31 | $23 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,520 | 12 | $47 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 8,125 | 59 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 7,050 | 17 | $0 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 6,300 | 11 | $12 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,640 | 64 | $0 | |
J9312 |
Injection, rituximab, 10 mg | 2,390 | 15 | $80 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 1,428. This provider delivers 94× the peer median.Open Payments
Industry payments received
All-time total
$3,045
Transactions
95
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $322.68 | |
| Genentech USA, Inc. | 11 | $274.90 | |
| Novartis Pharmaceuticals Corporation | 15 | $226.97 | |
| PFIZER INC. | 13 | $215.84 | |
| Janssen Biotech, Inc. | 8 | $168.48 | |
| ABBVIE INC. | 9 | $150.81 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $149.55 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $134.16 | |
| Daiichi Sankyo Inc. | 4 | $125.88 | |
| Genentech, Inc. | 1 | $125.44 | |
| Genmab U.S., Inc. | 1 | $115.06 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $106.03 | |
| Celgene Corporation | 4 | $93.17 | |
| Incyte Corporation | 4 | $84.67 | |
| SOBI, INC | 2 | $70.50 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
332
Patients
48
Total drug cost
$1,120,562
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 62 | 11 | $48,031 |
| Lenalidomide | Generic | 30 | 0 | $468,024 |
| Prednisone | Generic | 29 | 12 | $298 |
| Levothyroxine Sodium | Generic | 24 | 0 | $217 |
| Anastrozole | Generic | 23 | 0 | $648 |
| Acyclovir | Generic | 21 | 0 | $994 |
| Gabapentin | Generic | 21 | 0 | $346 |
| Abiraterone Acetate | Generic | 19 | 0 | $125,503 |
| Pantoprazole Sodium | Generic | 18 | 0 | $209 |
| Ibrance (Palbociclib) | Brand | 17 | 0 | $265,838 |
Hospital affiliations
Frequently asked questions
What is Dr. Steven Liu's medical specialty?
Dr. Steven Liu practices Hematology & Oncology Physician in Anchorage, AK.
Where does Dr. Steven Liu practice?
Dr. Steven Liu practices at 2925 Debarr RD, Anchorage, AK 995082983. Office phone: 9072793155.
What is Dr. Steven Liu's NPI?
Dr. Steven Liu's National Provider Identifier (NPI) is 1164462834, issued by NPPES.
Does Dr. Steven Liu accept Medicare assignment?
Yes. Dr. Steven Liu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Steven Liu commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110). Source: CMS Medicare Physician & Other Practitioners file.